Cleveland, MS35 Active Studies

Interstitial Cystitis Clinical Trials in Cleveland, MS

Find 35 actively recruiting interstitial cystitis clinical trials in Cleveland, MS. Connect with local research sites and explore new treatment options.

35
Active Trials
23
Sponsors
7,484
Enrolling

Recruiting Interstitial Cystitis Studies in Cleveland

About Interstitial Cystitis Clinical Trials in Cleveland

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 35 interstitial cystitis clinical trials recruiting participants in Cleveland, MS. These studies are seeking a combined 7,484 participants. Research is being sponsored by Bayer, University of Pennsylvania, Montefiore Medical Center and 20 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Cleveland — FAQ

Are there interstitial cystitis clinical trials in Cleveland?

Yes, there are 35 interstitial cystitis clinical trials currently recruiting in Cleveland, MS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Cleveland?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cleveland research site will contact you about next steps.

Are clinical trials in Cleveland free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cleveland studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 35 active trials in Cleveland are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated July 13, 2026 from ClinicalTrials.gov